AstraZeneca: all 4,196 studies
Page 23 of 42. Open to participants first (299), then studies with results posted, then the rest; newest registration first within each.
- A Study of the Cardiac Effects of ALXN2050 in Healthy AdultsCompletedNCT04660890Phase 1
- Observational Retrospective Study on Clinical Outcomes of Patients Receiving Benralizumab in Spain.CompletedNCT04648839
- Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid MalignanciesActive, not recruitingNCT04644068Phase 1/2
- A Study HB-201 in Patients With Newly Diagnosed HPV16+ Oropharynx or Locally Advanced Cervical CancerTerminatedNCT04630353Early Phase 1
- Assessment of Safety, Tolerability, Immunogenicity, and Pharmacokinetics of AZD3427CompletedNCT04630067Phase 1
- Study of ALXN2050 in Participants With Renal ImpairmentCompletedNCT04623710Phase 1
- A Study of MEDI9253 in Combination With Durvalumab in Select Solid TumorsTerminatedNCT04613492Phase 1
- Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung CancerActive, not recruitingNCT04612751Phase 1
- Study of the Metabolism of Danicopan in Healthy AdultsCompletedNCT04609696Phase 1
- Study of Radiolabeled ALXN2050 in Healthy Adult MalesCompletedNCT04609670Phase 1
- A Study of AZD0486 in Subjects With B-Cell Non-Hodgkin LymphomaActive, not recruitingNCT04594642Phase 1
- Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction CancerActive, not recruitingNCT04592913Phase 3
- A Study of Selumetinib in Chinese Paediatric and Adult Subjects With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas (PN)Active, not recruitingNCT04590235Phase 1
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of AZD3366 in Healthy Subjects, Japanese and Chinese SubjectsCompletedNCT04588727Phase 1
- Patient Characteristics, Persistence to Treatment and Outcome Events in Patients Treated With Ticagrelor 60 mg After Myocardial Infarction in Real-world Clinical PracticeCompletedNCT04568083
- Patient Palatability and Preference of 3 Potassium Binders in Patients With Chronic Kidney Disease and HyperkalaemiaCompletedNCT04566653
- A Study in Healthy Subjects to Assess Bioavailability (Proportion of a Drug Which Enters the Circulation to Have an Active Effect) of Acalabrutinib Tablet and Protonpump Inhibitor Effect (Members of a Class of Medications That Inhibits in Gastric Acid Production) for RabeprazoleCompletedNCT04564040Phase 1
- Drug Intensive Monitoring Study of Olaparib in Clinical Practice Among Chinese PatientsCompletedNCT04560452
- A Phase 1b Study of T-DXd Combinations in HER2-low Advanced or Metastatic Breast CancerActive, not recruitingNCT04556773Phase 1
- 'OLAP' (OLAparib Regulatory Post-marketing Surveillance)CompletedNCT04553926
- A Study of the Effects of Food and Age on DanicopanCompletedNCT04551599Phase 1
- A Study to Assess ACH-0145228 When Administered as Immediate Release Tablet Versus Powder-In-Capsule in Healthy Adult ParticipantsCompletedNCT04551586Phase 1
- Study of Durvalumab Versus Placebo in Combination With Definitive Chemoradiation Therapy in Patient With ESCCActive, not recruitingNCT04550260Phase 3
- A Study to Assess the Rel Bioavailability, Food Effect and Absolute Bioavailability on the Pharmacokinetics of AZD9833CompletedNCT04546347Phase 1
- A Phase 1 Study of AZD9833 in Japanese Women With ER Positive, HER2 Negative Advanced Breast CancerCompletedNCT04541433Phase 1
- AZD1222 Vaccine for the Prevention of COVID-19WithdrawnNCT04540393Phase 3
- A Phase 1b/2 Study of T-DXd Combinations in HER2-positive Metastatic Breast CancerActive, not recruitingNCT04538742Phase 1/2
- Evaluate the Safety Profile of BGF MDI in Chinese Patients With COPD in Routine Clinical PracticeCompletedNCT04536402
- Olaparib Real-world Utilization and Clinical Outcomes in France, Italy, and the UKCompletedNCT04532645
- A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)Active, not recruitingNCT04529772Phase 3
- Real-world Data on Stage III NSCLC Patients Treated With Durvalumab After Chemoradiotherapy in Asia Area (PACIFIC AA)CompletedNCT04529564
- An Open Non-comparative Study of the Efficacy and Safety of Aprotinin in Patients Hospitalized With COVID-19Status unknownNCT04527133Not applicable
- A Study to Evaluate MEDI5752 and Axitinib in Subjects With Advanced Renal Cell CarcinomaActive, not recruitingNCT04522323Phase 1
- First Time in Human Study of AZD8701 With or Without Durvalumab in Participants With Advanced Solid TumoursCompletedNCT04504669Phase 1
- Selumetinib Paediatric NF1 Japan StudyCompletedNCT04495127Phase 1
- A Study to Assess the Effect of Multiple Doses of AZD5718 on Pharmacokinetics of Oral Midazolam in Healthy SubjectsCompletedNCT04492709Phase 1
- A Study to Evaluate Effects of Proton-pump Inhibitor on Acalabrutinib Capsule When Administered Orally With COCA-COLA in Healthy ParticipantsCompletedNCT04489797Phase 1
- A Study to Evaluate Relative Bioavailability, Proton Pump Inhibitor (PPI) (Rabeprazole) Effect, Food Effect and Particle Size Effect of New Acalabrutinib Tablet in Healthy SubjectsCompletedNCT04488016Phase 1
- A Study to Assess Safety, Tolerability, PK and PD of AZD2693 in Non-alcoholic Steatohepatitis PatientsCompletedNCT04483947Phase 1
- A Phase 2 Study of T-DXd in Patients With Selected HER2 Expressing TumorsActive, not recruitingNCT04482309Phase 2
- HF Prevalence and Evolution of HF in DM II Patients at High RiskCompletedNCT04482283
- Evaluation of AZD8154 Concentrations in BloodTerminatedNCT04480879Phase 1
- A Study to Assess the Effect of Fluvoxamine and Smoking on Pharmacokinetics ( the Movement of Drugs Within the Body) of AZD4635 in Healthy VolunteersCompletedNCT04478513Phase 1
- Study to Assess the Pharmacokinetics and Safety of AZD9977 in Participants With Renal ImpairmentCompletedNCT04469907Phase 1
- Assessment of Hyperkalemia's Illness and Treatment Burden in Chronic Kidney Disease and Heart Failure Patients: HK Registry Pilot StudyCompletedNCT04466969
- Study of Adavosertib(AZD1775) in Japanese Patients With Advanced Solid TumoursCompletedNCT04462952Phase 1
- Evaluate the Safety of Linaclotide in IBS-C Patients in ChinaCompletedNCT04462900
- An INternational Frontline Ovarian Cancer Real World Management StudyCompletedNCT04460768
- Study of Danicopan in Participants of Japanese DescentCompletedNCT04451434Phase 1
- Multiple Ascending Dose Study of MEDI1341 in Patients With Parkinson's DiseaseCompletedNCT04449484Phase 1
- A Study of Acalabrutinib Suspension to Evaluate Relative Bioavailability and Proton-pump Inhibitor Effect in Healthy VolunteersCompletedNCT04435483Phase 1
- Prevalence of HRR-related Genes Mutations and Prognosis in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients in Real World SettingCompletedNCT04425200
- Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With OlaparibActive, not recruitingNCT04421963Phase 3
- A Study to Assess the Mass Balance Recovery, Pharmacokinetics, Metabolite Profile and Metabolite Identification of [14C]AZD4831CompletedNCT04407091Phase 1
- Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)Active, not recruitingNCT04379596Phase 2
- A Study to Evaluate the Safety and Pharmacokinetics With MEDI8367 Administered in Healthy Subjects, and in Subjects With Chronic Kidney DiseaseCompletedNCT04365218Phase 1
- Tezepelumab Phase 1 PK Study in Healthy Chinese SubjectsCompletedNCT04362410Phase 1
- SOLIRIS® (Eculizumab) Treatment of Participants With COVID-19No longer availableNCT04355494
- Study to Evaluate the Effect of Ticagrelor Versus Placebo in Reducing Vaso-Occlusive Crises Rate in Pediatric Patients With Sickle Cell Disease.WithdrawnNCT04293172Phase 3
- ChAracterisation of ItaliaN Severe Uncontrolled Asthmatic patieNts Key Features When Receiving BenralizumabCompletedNCT04272463
- A First-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD2373 After Single Dose Administration in Healthy Male Subjects of African Ancestry.CompletedNCT04269031Phase 1
- IPH5201 as Monotherapy or in Combination With Durvalumab +/- Oleclumab in Subjects With Advanced Solid Tumors.CompletedNCT04261075Phase 1
- ALXN1830 in Patients With Warm Autoimmune Hemolytic AnemiaWithdrawnNCT04256148Phase 2
- A Study to Evaluate the Effectiveness and Tolerability of a Second Maintenance Treatment in Participants With Ovarian Cancer, Who Have Previously Received Polyadenosine 5'Diphosphoribose [Poly (ADP Ribose)] Polymerase Inhibitor (PARPi) Treatment.WithdrawnNCT04239014Phase 2
- Investigating Safety, Tolerability, Efficacy and PK of Olaparib in Paediatric Patients With Solid TumoursCompletedNCT04236414Phase 1
- A Study to Assess the Effect AZD4831 in Japanese and Chinese Healthy VolunteersCompletedNCT04232345Phase 1
- Characterizing the Cross-sectional Approach to Investigate the Prevalence of Tissue BRCA1/2 Mutations in Newly Diagnosed Advanced Ovarian Cancer PatientsCompletedNCT04222465
- Patient-reported Outcomes in Real-world Use of Benralizumab in Patients With Severe Eosinophilic Asthma in BelgiumCompletedNCT04221802
- A Study of AZD0466 in Patients With Advanced Hematologic or Solid TumorsTerminatedNCT04214093Phase 1
- A Study to Assess the Amount of Drug Levels in Blood and Safety of AZD5718 Formulations in Healthy VolunteersCompletedNCT04210388Phase 1
- Safety and Tolerability Study of Cotadutide in Japanese Obese Subjects With Type 2 Diabetes MelitusCompletedNCT04208620Phase 1
- Real World Study in Locally Advanced or Metastatic NSCLC Patients, Progressed From First-line EGFR-TKI TherapyCompletedNCT04207775
- Real-life First Dose Effect of Fasenra in Patients With Severe Uncontrolled AsthmaCompletedNCT04200326
- Relative Bioavailability Study With Abediterol Administered Via Three Different Inhalation Devices in Healthy Volunteers.TerminatedNCT04199598Phase 1
- A Study of the Safety, Tolerability and Pharmacokinetics of MEDI0618 in Healthy VolunteersCompletedNCT04198558Phase 1
- Patient Reported Outcomes in Adults With Pediatric-onset Hypophosphatasia Treated With Strensiq® (Asfotase Alfa)CompletedNCT04195763
- Relieving Burden of Hypophosphatasia in Adults With Functional Impairment Due to Chronic DiseaseWithdrawnNCT04189315Phase 4
- A Study to Evaluate the Effect of AZD8154 Administered Via Nebulizer Once Daily in Subjects With Mild Allergic Asthma Challenged With an Inhaled AllergenWithdrawnNCT04187508Phase 2
- A Study in Healthy Male Subjects to Understand How Savolitinib When Taken With Midazolam Behaves Inside the BodyCompletedNCT04187456Phase 1
- Change in Patient-Reported Outcomes in Severe Eosinophilic Asthma Patients Treated With Benralizumab Under Real-life ConditionsCompletedNCT04184284
- A Study in Healthy Male Subjects to Understand How Savolitinib Behaves Inside the Body (Pharmacokinetics) When Administered Alone and in Combination With FamotidineCompletedNCT04179071Phase 1
- Study of Relationship Between Changes in Inflammation, Lung Function, Symptoms and Medication Use in COPD PatientsCompletedNCT04168216
- To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD8233 After Multiple Dose Administration in Subjects With DyslipidemiaCompletedNCT04155645Phase 1
- Novel Oncology Therapies in Combination With Adjuvant Chemo in High-risk MSS-CRCWithdrawnNCT04145193Phase 2
- A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese SubjectsCompletedNCT04142424Phase 1
- Study to Characterise Patients Receiving Benralizumab in the Framework of an Individualized Access Program in SpainCompletedNCT04126499
- US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI)TerminatedNCT04125290
- A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With ItraconazoleCompletedNCT04121910Phase 1
- A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone and in Combination With RifampicinCompletedNCT04118842Phase 1
- A Study Investigating the Pharmacokinetics of a Single Dose Administration of CotadutideCompletedNCT04091373Phase 1
- A Study to Assess the Drug Absorption Into the Blood After Administration of 3 Doses of AZD5718CompletedNCT04087187Phase 1
- A Multi-centre Study to Assess the Safety, Tolerability, and Pharmacokinetics of Capivasertib (AZD5363) in Combination With Novel Agents in Patients With Metastatic Prostate CancerCompletedNCT04087174Phase 1
- A Study to Evaluate the Amount of Drug That Becomes Available to the Blood Circulation When Inhaled by a Nebulizer and Dry Powder Inhaler in Healthy Subjects.CompletedNCT04072562Phase 1
- An Observational Study to Assess the Prevalence of Heart Failure in Type 2 Diabetes PatientsCompletedNCT04072523
- Post-Authorisation Safety Study of LesinuradWithdrawnNCT04072471
- Open Label, Multicenter, Real World Practice of Durvalumab (Imfinzi PMS)CompletedNCT04068168
- A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD6615 in Healthy SubjectsTerminatedNCT04055168Phase 1
- Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent ExacerbationsCompletedNCT04053634Phase 3
- Real World Evidence of PD-L1, TMB Prevalence and Efficacy of 1st Line Chemotherapy in These High or Low Population for Stage IV Urothelial CancerCompletedNCT04052113
- A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of LifeCompletedNCT04034992